News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tauriga Sciences Inc. (TAUG) Fully Retires The Secured Convertible Promissory Note Held By Typenex Co-Investment, LLC For Original Principal Amount Of $555,000


3/24/2014 9:13:07 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

LOS ANGELES, March 24, 2014 (GLOBE NEWSWIRE) -- Tauriga Sciences Inc. (OTCQB:TAUG) or ("Tauriga" or "the Company"), a diversified life sciences company with key assets that include license agreements, topical medicinal cannabis lotions, and a proprietary technology platform in the nanorobotics space, today announced that it has fully retired a convertible note held by Typenex Co-Investment, LLC ("Typenex") for the principal amount of $555,000 USD. On June 24, 2013, the Company entered into a Securities Purchase Agreement with Typenex, for the sale of an 8% convertible promissory note (the "Note") in the principal amount of $550,000 (which included Typenex's legal expenses in the amount of $7,500 and a $50,000 original issue discount). By retiring the Note, the Company has removed the corresponding debt from its balance sheet. Additionally the Company is working diligently to repay and retire the entirety of its remaining convertible debt and will update shareholders, once this important goal is accomplished.

Help employers find you! Check out all the jobs and post your resume.

Read at GlobeNewswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES